PRTA (Prothena) Shiller PE Ratio: (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRTA Prothena Corp PLC PRTA
74 GF Score
Price $8.35
GF Value $12.78
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Prothena Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Prothena  (NAS:PRTA) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Prothena Shiller PE Ratio Related Terms


Prothena Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Prothena's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prothena Shiller PE Ratio Chart

Prothena Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Prothena Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PRTA vs EVMN, EDIT, CCCC: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Prothena's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prothena Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prothena's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Prothena's Shiller PE Ratio falls into.


PRTA
74GF Score
Prothena Corp PLC PRTA
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prothena Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Prothena's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Prothena's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.3564/128.6700*128.6700
=-0.356

Current CPI (Jun. 2026) = 128.6700.

Prothena Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -1.260 100.274 -1.617
201612 -1.410 99.676 -1.820
201703 -0.990 100.374 -1.269
201706 -0.460 100.673 -0.588
201709 -1.370 100.474 -1.754
201712 -1.240 100.075 -1.594
201803 -1.260 100.573 -1.612
201806 -1.500 101.072 -1.910
201809 -0.616 101.371 -0.782
201812 -0.563 100.773 -0.719
201903 -0.523 101.670 -0.662
201906 -0.397 102.168 -0.499
201909 -0.488 102.268 -0.613
201912 -0.540 102.068 -0.681
202003 -0.591 102.367 -0.742
202006 -0.659 101.769 -0.833
202009 -0.766 101.072 -0.975
202012 -0.769 101.072 -0.979
202103 -0.913 102.367 -1.147
202106 0.583 103.364 0.726
202109 2.134 104.859 2.618
202112 -0.711 106.653 -0.858
202203 -0.777 109.245 -0.915
202206 -0.881 112.779 -1.005
202209 -0.974 113.504 -1.104
202212 0.118 115.436 0.131
202303 -0.893 117.609 -0.977
202306 -1.028 119.662 -1.105
202309 0.378 120.749 0.402
202312 -1.257 120.749 -1.340
202403 -1.345 120.990 -1.430
202406 1.215 122.318 1.278
202409 -1.097 121.594 -1.161
202412 -1.077 122.439 -1.132
202503 -1.118 123.405 -1.166
202506 -2.337 124.492 -2.415
202509 -0.679 124.810 -0.700
202512 -0.401 125.770 -0.410
202603 0.605 127.830 0.609
202606 -0.356 128.670 -0.356

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Prothena (PRTA) Overvalued in 2026?

Based on GuruFocus' analysis, Prothena stock appears to be undervalued. The current stock price of $8.35 is trading 34.7% below its estimated GF Value™ of $12.78. GuruFocus considers Prothena to be Possible Value Trap.

Key valuation signals for PRTA:

  • Shiller PE Ratio:
  • GF Value™: $12.78 vs. price of $8.35 (34.7% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the PRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Prothena Business Description

Other Exchanges 0Y3M:UK0PT:Germany
Address 77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, Dublin, IRL, D02 VK60
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.
74GF Score

Get the complete analysis for PRTA

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.35
Price
$12.78
GF Value